Skip to search formSkip to main contentSkip to account menu

Akinesia

Known as: akinesias 
Lack of movement.
National Institutes of Health

Related topics

Related topics

9 relations
ApraxiasHallervorden-Spatz SyndromeKUFOR-RAKEB SYNDROMELethal Congenital Contracture Syndrome 2

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, published in 1996 by the National… 
Review
2009
Review
2009
Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms
Highly Cited
2006
Highly Cited
2006
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
Highly Cited
2003
Highly Cited
2003
Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.
BACKGROUND Although the short-term benefits of bilateral stimulation of the subthalamic nucleus in patients with advanced… 
Highly Cited
2002
Highly Cited
2002
Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease
In an attempt to define clinically relevant models of akinesia and dyskinesia in 6‐hydroxydopamine (6‐OHDA)‐lesioned rats, we… 
Review
2002
Review
2002
Modeling Parkinson's Disease in Rats: An Evaluation of 6-OHDA Lesions of the Nigrostriatal Pathway
Human idiopathic Parkinson's disease (PD) is a progressive neurodegenerative disorder that is primarily characterized by… 
Highly Cited
1995
Highly Cited
1995
Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test
Methods for the assessment of akinesia in the unilateral rat Parkinson model have so far been lacking. The experiments reported… 
Highly Cited
1992
Highly Cited
1992
Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine
Using positron emission tomography (PET) we previously showed that activation of the putamen, supplementary motor area, and… 
Highly Cited
1990
Highly Cited
1990
Reversal of experimental parkinsonism by lesions of the subthalamic nucleus.
Although it is known that Parkinson's disease results from a loss of dopaminergic neurons in the substantia nigra, the resulting… 
Highly Cited
1983
Highly Cited
1983
A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
A syndrome similar to idiopathic parkinsonism developed after intravenous self-administration of an illicit drug preparation in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License